scispace - formally typeset
H

Hiroshi Yamaguchi

Researcher at Nippon Telegraph and Telephone

Publications -  571
Citations -  14406

Hiroshi Yamaguchi is an academic researcher from Nippon Telegraph and Telephone. The author has contributed to research in topics: Resonator & Molecular beam epitaxy. The author has an hindex of 47, co-authored 519 publications receiving 13016 citations. Previous affiliations of Hiroshi Yamaguchi include Osaka University & Imperial College London.

Papers
More filters
Journal ArticleDOI

Parametrically pumped ultrahigh Q electromechanical resonator

TL;DR: The spectral purity of an electromechanical resonance (quality factor Q) can be enhanced by more than one order of magnitude to ∼2.5×106 by parametrically exciting the fundamental mode via double frequency modulations to the spring constant mediated by the piezoelectric effect as mentioned in this paper.
Journal ArticleDOI

Severe Respiratory Failure and Torsades de Pointes Induced by Disopyramide in a Patient with Myasthenia Gravis

TL;DR: It is suggested that the anti-cholinergic effects of disopyramide can induce MG crisis and should therefore be carefully considered when disopyramside is used to treat AF in patients with MG.
Journal ArticleDOI

Effect of pravastatin on progression of coronary atherosclerosis in patients after coronary artery bypass surgery.

TL;DR: Pravastatin can potentially reduce atherosclerotic progression in both the bypass graft and native coronary arteries of patients after CABG and the global change score indicated a significant pravastsatin-mediated reduction in plaque progression.
Journal ArticleDOI

Flexibility impaired by mutations revealed the multifunctional roles of the loop in glutathione synthetase.

TL;DR: The present results suggest that adjustability of the loop to the closed state is required for the recognition of the substrates, gamma-Glu-Cys and glycine, and for the chemical interactions with the bound substrates.
Journal ArticleDOI

Thiazolidinediones, dyslipidaemia and insulin resistance syndrome.

TL;DR: Thiazolidinediones, which are recently introduced insulin sensitizing agents, have been shown to be effective not only in reducing elevated glucose levels, but also in improving the other metabolic abnormalities associated with insulin resistance.